Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma

Annals of Surgery

Volumn 251, Issue 4, 2010, Pages 675-681

  Ito, Kaori ^a   Ito, Hiromichi ^a   Allen, Peter J ^a   Gonen, Mithat ^b   Klimstra, David ^c   D'Angelica, Michael I ^a   Fong, Yuman ^a   Dematteo, Ronald P ^a   Brennan, Murray F ^a   Blumgart, Leslie H ^a   Jarnagin, William R ^a  

^a Biostatist Epidemiol St Jude C   (United States)

^b Division of Biostatistics and Epidemiology   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CANCER; BILIARY TRACT SURGERY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISTAL BILE DUCT ADENOCARCINOMA; EXTRAHEPATIC BILE DUCT CANCER; FEMALE; HILAR CHOLANGIOCARCINOMA; HISTOLOGY; HUMAN; LOG RANK TEST; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; CHEMOTHERAPY, ADJUVANT; CHOLANGIOCARCINOMA; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 77950863454     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181d3d2b2     Document Type: Article

References (31)

1. Jarnagin WR, D'Angelica M, Blumgart LH. Intrahepatic and extrahepatic biliary cancer. In: Blumgart LH, ed. Surgery of the Liver, Biliary Tract, and Pancreas. Philadelphia, PA: Saunder Elsevier; 2007:783-826.
2. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234: 507-517; discussion 517-519.
3. Akoad M, Jenkins R. Proximal biliary malignancy. Surg Clin North Am. 2008;88:1409-1428, x-xi.
4. Veillette G, Castillo CF. Distal biliary malignancy. Surg Clin North Am. 2008;88:1429-1447, xi.
5. Aljiffry M, Abdulelah A, Walsh M, et al. Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature. J Am Coll Surg. 2009;208:134-147.
6. Allen PJ, Reiner AS, Gonen M, et al. Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. HPB (Oxford). 2008;10:341-346.
7. DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245:755-762.
8. Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 2001;233:385-392.
9. Yoshida T, Matsumoto T, Sasaki A, et al. Prognostic factors after pancre-atoduodenectomy with extended lymphadenectomy for distal bile duct cancer. Arch Surg. 2002;137:69-73.
10. AJCC Cancer Staging Handbook. 6th ed. New York, NY: Springer; 2002.
11. Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340:908-914.
12. Bunt AM, Hermans J, Smit VT, et al. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol. 1995;13:19-25.
13. Bunt AM, Hermans J, van de Velde CJ, et al. Lymph node retrieval in a randomized trial on western-type versus Japanese-type surgery in gastric cancer. J Clin Oncol. 1996;14:2289-2294.
14. Bunt AM, Hogendoorn PC, van de Velde CJ, et al. Lymph node staging standards in gastric cancer. J Clin Oncol. 1995;13:2309-2316.
15. Karpeh MS, Leon L, Klimstra D, et al. Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Ann Surg. 2000;232:362-371.
16. Tepper JE, O'Connell MJ, Niedzwiecki D, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol. 2001;19: 157-163.
17. Caplin S, Cerottini JP, Bosman FT, et al. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer. 1998;83:666-672.
18. Ratto C, Sofo L, Ippoliti M, et al. Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance. Dis Colon Rectum. 1999;42:143-154; discussion 154-158.
19. Brennan MF, Kattan MW, Klimstra D, et al. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004;240:293-298.
20. House MG, Gonen M, Jarnagin WR, et al. Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg. 2007;11:1549-1555.
21. Pawlik TM, Gleisner AL, Cameron JL, et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery. 2007;141:610-618.
22. Schwarz RE, Smith DD. Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on US population data. J Gastrointest Surg. 2007;11:158-165.
23. Jarnagin WR, Bowne W, Klimstra DS, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg. 2005;241:703-712; discussion 712-714.
24. Endo I, House MG, Klimstra DS, et al. Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma. Ann Surg Oncol. 2008;15:2104-2112.
25. Fong Y, Blumgart LH, Lin E, et al. Outcome of treatment for distal bile duct cancer. Br J Surg. 1996;83:1712-1715.
26. Hermanek P, Giedl J, Dworak O. Two programmes for examination of regional lymph nodes in colorectal carcinoma with regard to the new pN classification. Pathol Res Pract. 1989;185:867-873.
27. Compton CC. Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix: a basis for checklists. Cancer Committee. Arch Pathol Lab Med. 2000;124: 1016-1025.
28. Albores-Saavedra J, Heffess C, Hruban RH, et al. Recommendations for the reporting of pancreatic specimens containing malignant tumors. The Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol. 1999;111:304-307
29. Recommendations for the reporting of pancreatic specimens containing malignant tumors. Association of Directors of Anatomic and Surgical Pathology. Hum Pathol. 1998;29:893-895.
30. Compton CC, Henson DE. Protocol for the examination of specimens removed from patients with carcinoma of the exocrine pancreas: a basis for checklists. Cancer Committee, College of American Pathologists. Arch Pathol Lab Med. 1997;121:1129-1136.
31. Leonard GD, O'Reilly EM. Biliary tract cancers: current concepts and controversies. Expert Opin Pharmacother. 2005;6:211-223.